Clinical trials
Phase 1/2 Osteosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 15 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Peking University People's Hospital | 3 |
| St. Jude Children's Research Hospital | 3 |
| Children's Oncology Group | 2 |
| Milton S. Hershey Medical Center | 2 |
| National Cancer Institute (NCI) | 2 |
| AlaMab Therapeutics (Shanghai) Inc. | 1 |
| Bambino Gesù Hospital and Research Institute | 1 |
| Bayer | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteosarcoma | 47 |
| Sarcoma | 17 |
| Sarcoma, Ewing | 17 |
| Neuroblastoma | 15 |
| Rhabdomyosarcoma | 14 |
| Sarcoma, Synovial | 8 |
| Rhabdoid Tumor | 6 |
| Melanoma | 5 |
| Neuroectodermal Tumors, Primitive, Peripheral | 5 |
| Recurrence | 5 |
Trials
Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.